8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2010-05-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0910668107PMID 20453196PMCID PMC2906844
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-range enhancers on 8q24 regulate c-Myc

  2010cited by this paper
• Upregulation of c-MYC in cis through a Large Chromatin Loop Linked to a Cancer Risk-Associated Single-Nucleotide Polymorphism in Colorectal Cancer Cells

  2010cited by this paper
• Human genetic variation and its contribution to complex traits

  2009cited by this paper
• Histone modifications at human enhancers reflect global cell-type-specific gene expression

  2009cited by this paper
• Evaluation of the 8q24 prostate cancer risk locus and MYC expression.

  2009cited by this paper
• Discovery and Annotation of Functional Chromatin Signatures in the Human Genome

  2009cited by this paper
• The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling

  2009cited by this paper
• The 8q24 cancer risk variant rs6983267 demonstrates long-range interaction with MYC in colorectal cancer

  2009cited by this paper
• CTCF: master weaver of the genome.

  2009cited by this paper
• Common Regulatory Variation Impacts Gene Expression in a Cell Type–Dependent Manner

  2009cited by this paper
• Genomic interactions: chromatin loops and gene meeting points in transcriptional regulation.

  2009cited by this paper
• Functional Enhancers at the Gene-Poor 8q24 Cancer-Linked Locus

  2009cited by this paper
• ChIP-seq accurately predicts tissue-specific activity of enhancers

  2009cited by this paper
• Genome-wide association study identifies novel breast cancer susceptibility loci

  2008cited by this paper
• Sequence variant on 8q24 confers susceptibility to urinary bladder cancer

  2008cited by this paper
• How the c-myc promoter works and why it sometimes does not.

  2008cited by this paper
• Multiple loci with different cancer specificities within the 8q24 gene desert.

  2008cited by this paper
• Multiple regions within 8q24 independently affect risk for prostate cancer

  2007cited by this paper
• Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome

  2007cited by this paper
• Genome-wide association study identifies novel breast cancer susceptibility loci

  2007cited by this paper
• High-resolution profiling of histone methylations in the human genome.

  2007cited by this paper
• A positive role for NLI/Ldb1 in long-range beta-globin locus control region function.

  2007cited by this paper
• A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21

  2007cited by this paper
• Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24

  2007cited by this paper
• Mapping Chromatin Interactions by Chromosome Conformation Capture

  2006cited by this paper
• Guidelines: From artificial evolution to computational evolution: a research agenda

  2006cited by this paper
• SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes

  2006cited by this paper
• Insulators: exploiting transcriptional and epigenetic mechanisms

  2006cited by this paper
• Proximity among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1.

  2005cited by this paper
• High‐Throughput Real‐Time Quantitative Reverse Transcription PCR

  2005cited by this paper
• Spatial organization of gene expression: the active chromatin hub

  2003cited by this paper
• Capturing Chromosome Conformation

  2002cited by this paper

• The possibility of prognostic and functional values of the 8q24 and 20q13 chromosomal bands in colorectal cancer

  2026cites this paper
• Targeting β-catenin degradation with GSK3β inhibitors induces cell death in acute lymphoblastic leukemia

  2026cites this paper
• Association between methylation quantitative trait loci and colorectal cancer risk, survival and cancer recurrence

  2025cites this paper
• OLIVE Provides Rapid Visualization and Analysis of Chromatin Tracing Experiments

  2025cites this paper
• Integrative CRISPR Screens and RNA-Omics Discover an Essential Role for PUF60-3’ Splice Site Interactions in Cancer Progression

  2025cites this paper
• Enhancer regulatory networks globally connect non-coding breast cancer loci to cancer genes

  2025cites this paper
• Rewiring cancer epigenome: lncRNA as modulator of chromatin architecture and neoplastic transformation

  2025cites this paper
• Augmented prehabilitation – is there a role for glucocorticoids and/or anabolic steroids to improve surgical outcomes?

  2024cites this paper
• Factors Involved in Prostate Cancer Disparity in African Americans: from Health System to Molecular Mechanisms

  2024cites this paper
• TDP2 is a regulator of estrogen-responsive oncogene expression

  2024cites this paper
• dCas9 Tells Tales: Probing Gene Function and Transcription Regulation in Cancer

  2024cites this paper
• Novel insights into RB1 in prostate cancer lineage plasticity and drug resistance

  2024cites this paper
• Inhibition of Prostate Cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling

  2024cites this paper
• NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling

  2024cites this paper
• CCAT1 lncRNA is chromatin-retained and post-transcriptionally spliced

  2024cites this paper
• Nanomedicine for Prostate Cancer Treatment

  2024cites this paper
• TDP 2 modulates the expression of estrogen-responsive oncogenes

  2024cites this paper
• The identification of essential cellular genes is critical for validating drug targets.

  2024cites this paper
• Prohibitin 2 orchestrates long noncoding RNA and gene transcription to accelerate tumorigenesis

  2024cites this paper
• Single-Sample Networks Reveal Intra-Cytoband Co-Expression Hotspots in Breast Cancer Subtypes

  2024cites this paper
• Firefighting, per‐ and polyfluoroalkyl substances, and DNA methylation of genes associated with prostate cancer risk

  2024cites this paper
• Unveiling the Prognostic Significance of Long Non-Coding RNA (lncRNA) PCAT1 in Invasive Breast Carcinoma

  2024cites this paper
• Roles of CDK12 mutations in PCa development and treatment.

  2024cites this paper
• Dissecting transcription of the 8q24-MYC locus in prostate cancer recognizes the equilibration between androgen receptor direct and indirect dual-functions

  2023influential citation
• Enhancer regulatory networks globally connect non-coding breast cancer loci to cancer genes

  2023cites this paper
• Predicting the molecular functions of regulatory genetic variants associated with cancer

  2023cites this paper
• Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers

  2023cites this paper
• Alterations and Co-Occurrence of C-MYC, N-MYC, and L-MYC Expression are Related to Clinical Outcomes in Various Cancers

  2023cites this paper
• The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer

  2023cites this paper
• Comprehensive machine learning-generated classifier identifies pro-metastatic characteristics and predicts individual treatment in pancreatic cancer: A multicenter cohort study based on super-enhancer profiling

  2023cites this paper
• Dietary omega-6/omega-3 fatty acids and risk of prostate cancer; Is there any potential interaction by organophosphate insecticides among the agricultural health study population.

  2023cites this paper
• MYC reshapes CTCF-mediated chromatin architecture in prostate cancer

  2023cites this paper
• Shared requirement for MYC upstream super-enhancer region in tissue regeneration and cancer

  2023cites this paper
• Long-range gene regulation in hormone-dependent cancer

  2023cites this paper
• Androgen receptor and MYC transcriptomes are equilibrated in multilayer regulatory circuitries in prostate cancer

  2023cites this paper
• The Revelation of Continuously Organized, Co-Overexpressed Protein-Coding Genes with Roles in Cellular Communications in Breast Cancer

  2022cites this paper
• Reconstructing protein interactions at enhancer-promoter regions in prostate cancer

  2022cites this paper
• Prostate Cancer Epigenetic Plasticity and Enhancer Heterogeneity: Molecular Causes, Consequences and Clinical Implications.

  2022cites this paper
• A novel oncogenic enhancer of estrogen receptor-positive breast cancer

  2022cites this paper
• ‘Breast Cancer Resistance Likelihood and Personalized Treatment Through Integrated Multiomics’

  2022cites this paper
• Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution

  2022cites this paper
• Clinical Significance of Genetic Variants in Colon Cancer

  2022cites this paper
• Deep learning for MYC binding site recognition

  2022influential citation
• Transposon-activated POU5F1B promotes colorectal cancer growth and metastasis

  2022cites this paper
• Targeting of non-coding RNAs encoded by novel MYC enhancers inhibits the proliferation of human hepatic carcinoma cells in vitro

  2022cites this paper
• Alu insertion variants alter gene transcript levels

  2021cites this paper
• Unravelling similarities and differences in the role of circular and linear PVT1 in cancer and human disease

  2021cites this paper
• What is beyond LncRNAs in breast cancer: A special focus on colon cancer-associated Transcript-1 (CCAT-1)

  2021cites this paper
• Association between genetic variations at 8q24 and prostate cancer risk in Mexican Men

  2021cites this paper
• Chromosome compartmentalization alterations in prostate cancer cell lines model disease progression

  2021cites this paper
• An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields

  2021cites this paper
• Insights into the Links between MYC and 3D Chromatin Structure and Epigenetics Regulation: Implications for Cancer Therapy

  2021cites this paper
• A nuclear polymorphism at the 8q24 region is associated with improved survival time and chemo-response in high-grade serous ovarian cancer

  2021influential citation
• Mechanistic insights into genetic susceptibility to prostate cancer.

  2021cites this paper
• Long noncoding RNA CCAT1 rs67085638 SNP contribution to the progression of gastric cancer in a Polish population

  2021cites this paper
• Integrative analysis of immune‐related multi‐omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma

  2021cites this paper
• The 8q24 Rs10090154c>T Gene Variant and Its Association with the Risk of Prostate Cancer: A Systematic Review and Meta-analysis

  2021cites this paper
• Investigating the association between rs6983267 polymorphism and susceptibility to gastrointestinal cancers in Iranian population

  2021cites this paper
• Functional Interrogation of Enhancer Connectome Prioritizes Candidate Target Genes at Ovarian Cancer Susceptibility Loci

  2021cites this paper
• Chrom-Lasso: a lasso regression-based model to detect functional interactions using Hi-C data

  2021cites this paper
• CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer

  2021cites this paper
• Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species

  2021cites this paper
• Does Subtelomeric Position of COMMD5 Influence Cancer Progression?

  2021cites this paper
• Association of genetic variants with prostate cancer in Africa: a concise review

  2021cites this paper
• Targeting MYC-inducing enhancer-associated noncoding (MYC-IEANC) RNAs inhibits the proliferation of HCC cells

  2021cites this paper
• Transcriptionally active enhancers in human cancer cells

  2021influential citation
• Prostate cancer

  2021cites this paper
• Identification of a Goat Intersexuality-Associated Novel Variant Through Genome-Wide Resequencing and Hi-C

  2021cites this paper
• Alterations in chromosome spatial compartmentalization classify prostate cancer progression

  2021cites this paper
• Androgen receptor and MYC equilibration centralizes on developmental super-enhancer

  2021cites this paper
• PVT1: a long non-coding RNA recurrently involved in neoplasia-associated fusion transcripts.

  2021cites this paper
• H3k27ac-HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility

  2020cites this paper
• Transcription factors in epithelial ovarian cancer: Histotype-specific drivers and novel therapeutic targets.

  2020cites this paper
• The Impact of Whole Genome Data on Therapeutic Decision-Making in Metastatic Prostate Cancer: A Retrospective Analysis

  2020cites this paper
• Ranking Series of Cancer-Related Gene Expression Data by Means of the Superposing Significant Interaction Rules Method

  2020cites this paper
• Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.

  2020cites this paper
• Capture Hi-C: Characterization of chromatin contacts

  2020cites this paper
• The Oncogenic Potential of the Centromeric Border Protein FAM84B of the 8q24.21 Gene Desert

  2020cites this paper
• At the interface

  2020cites this paper
• PVT1 Long Non-coding RNA in Gastrointestinal Cancer

  2020cites this paper
• Emerging Role and Therapeutic Potential of lncRNAs in Colorectal Cancer

  2020cites this paper
• MYC DNA Methylation in Prostate Tumor Tissue is Associated with Gleason Score

  2020cites this paper
• Preventing cancer by long-term partial Myc suppression

  2020cites this paper
• Cancer Progress and Priorities: Prostate Cancer

  2020cites this paper
• Prognostic and Predictive Significance of Eukaryotic Elongation Factor 1D (eEF1D) in Breast Cancer: A Potential Marker of Response to Endocrine Therapy

  2020cites this paper
• Molecular Basics on Genitourinary Malignancies

  2019cites this paper
• Deciphering regulatory networks in the mouse genome

  2019cites this paper
• Urologic Oncology

  2019cites this paper
• The Many Faces of Gene Regulation in Cancer: A Computational Oncogenomics Outlook

  2019cites this paper
• Long non-coding RNAs in prostate cancer: Biological and clinical implications.

  2019cites this paper
• Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors.

  2019cites this paper
• Modeling three-dimensional genomic organization in evolution and pathogenesis.

  2019cites this paper
• Super-enhancers in cancer.

  2019cites this paper
• From Super-Enhancer Non-coding RNA to Immune Checkpoint: Frameworks to Functions

  2019cites this paper
• GERMLINE COPY NUMBER VARIATION OF CANCER SUSCEPTIBILITY 8 GENE IN BREAST CANCER RISK AND PROGNOSIS

  2019cites this paper
• A high-resolution 3D epigenomic map reveals insights into the creation of the prostate cancer transcriptome

  2019cites this paper
• An enhancer from the 8 q 24 prostate cancer risk region is sufficient to direct reporter gene expression to a subset of prostate stem-like epithelial cells in transgenic mice

  2019cites this paper
• Long Non-coding RNAs in Prostate Cancer: Functional Roles and Clinical Implications.

  2019cites this paper
• Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1

  2019cites this paper
• Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques

  2019cites this paper